U.S. Markets open in 8 hrs 35 mins

Dr. Reddy's Laboratories Limited (RDY)

NYSE - NYSE Delayed Price. Currency in USD
Add to watchlist
38.30-3.37 (-8.09%)
At close: 4:02PM EDT
People also watch
HDBWITIBNTTMINFY
Full screen
Previous Close41.67
Open40.74
Bid0.00 x
Ask0.00 x
Day's Range37.83 - 40.84
52 Week Range37.03 - 50.10
Volume565,724
Avg. Volume257,115
Market Cap6.21B
Beta0.11
PE Ratio (TTM)34.44
EPS (TTM)N/A
Earnings DateN/A
Dividend & Yield0.00 (0.00%)
Ex-Dividend Date2016-07-14
1y Target EstN/A
Trade prices are not sourced from all markets
  • Capital Cube15 days ago

    ETFs with exposure to Dr. Reddy’s Laboratories Ltd. : July 12, 2017

    Categories: ETFs Yahoo FinanceClick here to see latest analysis ETFs with exposure to Dr. Reddy’s Laboratories Ltd. Here are 5 ETFs with the largest exposure to RDY-US. Comparing the performance and risk of Dr. Reddy’s Laboratories Ltd. with the ETFs that have exposure to it gives us some ETF choices that could give us similar returns with lower ... Read more (Read more...)

  • Capital Cubelast month

    ETFs with exposure to Dr. Reddy’s Laboratories Ltd. : June 27, 2017

    Categories: ETFs Yahoo FinanceClick here to see latest analysis ETFs with exposure to Dr. Reddy’s Laboratories Ltd. Here are 5 ETFs with the largest exposure to RDY-US. Comparing the performance and risk of Dr. Reddy’s Laboratories Ltd. with the ETFs that have exposure to it gives us some ETF choices that could give us similar returns with lower ... Read more (Read more...)

  • Dr. Reddy’s Laboratories Ltd. :RDY-US: Earnings Analysis: Q4, 2017 By the Numbers : June 26, 2017
    Capital Cubelast month

    Dr. Reddy’s Laboratories Ltd. :RDY-US: Earnings Analysis: Q4, 2017 By the Numbers : June 26, 2017

    Categories: Yahoo FinanceGet free summary analysis Dr. Reddy’s Laboratories Ltd. reports financial results for the quarter ended March 31, 2017. We analyze the earnings along side the following peers of Dr. Reddy’s Laboratories Ltd. – Pfizer Inc., Teva Pharmaceutical Industries Limited Sponsored ADR, Cipla Limited Sponsored GDR 144A, GlaxoSmithKline plc Sponsored ADR, Novartis AG Sponsored ADR and ... Read more (Read more...)